Hem › Kronisk lymfatisk leukemi › Minnesota › Rochester
Kliniska studier för Kronisk lymfatisk leukemi i Rochester, MN
19 studier för Kronisk lymfatisk leukemi söker deltagare vid platser i och runt Rochester (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekryterarFas 2
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
RekryterarFas 1/2
- Research Site, Rochester
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekryterarFas 3
- Mayo Clinic Rochester, Rochester
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekryterarFas 1/2
- Mayo Clinic Rochester, Rochester
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
RekryterarFas 3
- Mayo Clinic Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekryterarFas 3
- Mayo Clinic Rochester, Rochester
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
RekryterarFas 1
- Mayo Clinic Rochester, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekryterarFas 1/2
- Mayo Clinic, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekryterarFas 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
RekryterarFas 2
- Mayo Clinic, Rochester
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
RekryterarFas 1
- Mayo Clinic in Rochester, Rochester
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
RekryterarFriska volontärer välkomna
- Mayo Clinic in Rochester, Rochester
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
RekryterarObservationsstudieFriska volontärer välkomna
- Mayo Clinic in Rochester, Rochester
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekryterarFas 2
- Mayo Clinic in Rochester, Rochester
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
RekryterarFas 4
- Mayo Clinic- Minnesota, Rochester
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
RekryterarFas 4
- Mayo Clinic- Minnesota, Rochester
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
RekryterarObservationsstudie
- Mayo Clinic in Rochester, Rochester
Family Study of Lymphoproliferative Disorders
RekryterarObservationsstudieFriska volontärer välkomna
- Mayo Clinic, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
RekryterarFas 1
- Mayo Clinic in Rochester, Rochester
Kronisk lymfatisk leukemi-studier i andra städer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Washington, DC22 studier
- Seattle, WA20 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Chicago, IL14 studier
- Cincinnati, OH14 studier
- Nashville, TN13 studier
Andra studier i Rochester
- Bröstcancer42 studier
- Icke-småcellig lungcancer37 studier
- Metastaserande cancer31 studier
- Cancer (alla typer)30 studier
- Kolorektal cancer29 studier
- Äggstockscancer29 studier
- Multipelt myelom24 studier
- Prostatacancer22 studier
- Hjärtsvikt22 studier
- Bukspottkörtelcancer22 studier
- Lungcancer20 studier
- Endometriecancer20 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.